Background: Although granulocyte transfusions are recommended for neut
ropenic patients with bacterial infections that are unresponsive to an
tibiotic therapy, the presence of white cell (WBC) antibodies in the r
ecipient can render these transfusions ineffective. Study Design and M
ethods: A 25-year-old man with chronic granulomatous disease experienc
ed a pulmonary transfusion reaction while receiving granulocyte transf
usions, and he was found to be immunized to neutrophil antigen NA2. A
retrospective study of alloimmunization to HLA and neutrophil antigens
in 18 patients with chronic granulomatous disease who had also receiv
ed repeated granulocyte transfusions was then performed. Sera were tes
ted in lymphocytotoxicity, granulocyte agglutination, granulocyte immu
nofluorescence, monoclonal antibody immobilization of granulocyte anti
gen, and immunoprecipitation assays. Results: After the granulocyte tr
ansfusions, sera from 14 of the 18 patients contained WBC antibodies.
Seven sera samples reacted in the lymphocytotoxicity, granulocyte immu
nofluorescence, and granulocyte agglutination assays; seven reacted in
the lymphocytotoxicity and granulocyte immunofluorescence assays but
not the granulocyte agglutination assay, and four did not react. When
the monoclonal antibody immobilization of granulocyte antigen assay wa
s used, three sera samples reacted with Fc gamma receptor III, three w
ith the 58- to 64-kDa protein carrying the neutrophil antigen NBI, one
with CD11a, and one with CD18, Antibodies from three patients immunop
recipitated a neutrophil protein of 60 kDa, Overall, antibodies to neu
trophil antigens other than HLA could be detected in sera from eight p
atients, Transfusion reactions occurred in 11 of the 14 individuals wi
th WBC antibodies and in none of the 4 without antibodies, Seven pulmo
nary reactions occurred in patients with WBC antibodies, The patients
with WBC antibodies were given significantly more granulocyte concentr
ates (78 +/- 65 vs. 29 +/- 15 units, p<0.05). Conclusion: Recipients o
f granulocyte transfusions often become alloimmunized. Screening for W
BC antibodies periodically during transfusions, after adverse reaction
s, or before subsequent transfusions is indicated, if WBC antibodies a
re present, no further granulocyte transfusions should be given unless
the granulocytes are collected from HLA- and/or neutrophil antigen-co
mpatible donors.